Related Experiment Video
Updated: Apr 27, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.7K
The limitations of theoretical dose modeling for yttrium-90 radioembolization
David Liu1, Darren Klass1, Mark Westcott2
1Angio/Interventional Section, Department of Radiology, University of British Columbia, JP G873, Vancouver, BC V5Z1M9, Canada.
Journal of Vascular and Interventional Radiology : JVIR
|June 28, 2014
Abstract
No abstract available in PubMed .

